Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalenc… Ended

2024-514198-23-00 Healthy volunteers, therapeutic indication not studied 2 2025-03-05
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin Ended

2024-520303-62-00 Healthy volunteers 2 2025-03-04
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single do… Ended

2024-519661-22-00 Healthy volunteers 3 2025-03-03
Drug-Drug Interaction between Empagliflozin 25 mg Film-Coated Tablets and Alogliptin 25 mg Film-Coated Tablets in Healthy Participants Under… Ended

2025-520459-10-00 No medical condition. 3 2025-02-18
Drug-Drug Interaction between Alogliptin 25 mg Film-Coated Tablets and Empagliflozin 25 mg Film-Coated Tablets in Healthy Participants Under… Ended

2025-520460-18-00 No medical condition. 3 2025-02-18
Randomized, open-label clinical trial (Phase 1) to evaluate safety, tolerability, pharmacokinetics and food effects of a single dose of IM-2… Ended

2024-518155-37-00 Healthy volunteers 3 2025-02-14
A single center, open-label pilot study in healthy subjects using dermal open flow microperfusion to collect body fluids for bioanalytical m… Ended

2024-515780-62-00 No medical condition is being investigated in this clin 3 2025-02-05
A study in healthy people to compare how 3 different formulations of survodutide are taken up in the body Ended

2024-516529-30-00 Healthy volunteer trial 3 2025-01-31
Bioequivalence clinical trial of two formulations of vortioxetine. Ended

2024-519398-21-00 Healthy volunteers 2 2025-01-30
An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo… Ended

2024-514496-18-01 Hepatocellular carcinoma, renal cell carcinoma and diff 3 2025-01-30
Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions. Ended

2024-513480-37-00 No medical condition. 2 2025-01-28
Bioequivalence study of GP-IMP-001 with regards to reference product Ended

2024-515889-14-00 healthy volunteers 2 2025-01-22
A study in healthy people to test whether BI 1291583 influences the amount of dabigatran in the body Ended

2024-516256-18-00 Healthy volunteer trial 3 2025-01-20
A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection in… Ended

2024-516575-32-00 Allergic reactions (Type 1), including anaphylaxis, idi 3 2025-01-10
A drug-drug interaction trial in healthy female participants to investigate the effect of aprocitentan on combined hormonal contraceptives. Ended

2024-517224-19-00 Not applicable - healthy volunteer trial 3 2025-01-06
With Ponatinib on the track for treatment-free-remission in chronic myeloid leukemia Ended

2024-518971-76-00 chronic myeloid leukemia in chronic phase 4 2024-12-21
Bioequivalence clinical trial of two formulations of linagliptin/metformin. Ended

2024-516081-11-00 Healthy volunteers 2 2024-12-13
A Study to evaluate the effect of a high-fat meal on the Pharmacokinetics of the Selective MET kinase Inhibitor DO-2 in subjects in good hea… Ended

2024-518581-27-00 Healthy volunteer 3 2024-12-12
A study to test how different doses of BI 3731579 are tolerated by healthy people Ended

2024-517209-95-00 Healthy volunteer trial 3 2024-12-11
A study to assess the effects of efgartigimod on emasiprubart in healthy adult participants Ended

2024-517511-70-00 not applicable 3 2024-12-04
KF2024#1 trial: Esketamine interaction study Ended

2024-516892-34-00 healthy volunteers 2 2024-12-03
Bioequivalence of Metamizole Sodium 500 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions. Ended

2024-514447-29-00 No medical condition. 2 2024-12-02
Bioequivalence clinical trial of two formulations of linagliptin/metformin Ended

2024-515076-13-00 Healthy volunteers 2 2024-11-19
Randomized, open-label, single-dose, two-period, cross-over, bioequivalence study comparing Linagliptin 5 mg film-coated tablets (Vipharm S.… Ended

2024-514678-35-00 Bioequivalence study in healthy volunteers under fastin 2 2024-11-15